Salish Biosciences is pleased to announce that it has licensed Sapio’s Low-Code, No-Code informatics platform in Sapio’s Cloud environment to support its clinical lab operations. The company selected Sapio’s Clinical LIMS solution due to its ease of configuration, extensive support for next-generation sequencing (NGS), and detailed key performance indicators (KPIs).<\/p>\n\n\n\n
Sapio’s platform offers a range of features and capabilities that make it an ideal fit for Salish Biosciences‘ clinical lab operations, including the ability to quickly and easily configure workflows and the comprehensive support for NGS. The detailed KPIs provided by the platform will also help the company to track and monitor the performance of its lab operations.<\/p>\n\n\n\n
Salish Biosciences is committed to providing high-quality clinical lab services and is confident that Sapio’s platform will help it to deliver the best possible results for its clients. The company looks forward to working with Sapio and leveraging the full capabilities of its informatics platform.<\/p>\n","protected":false},"excerpt":{"rendered":"Salish sees operational benefits from Sapio’s end to end LIMS platform Salish Biosciences is pleased to announce that it has licensed Sapio’s Low-Code, No-Code informatics platform in Sapio’s Cloud environment to support its clinical lab operations. The company selected Sapio’s Clinical LIMS solution due to its ease of configuration, extensive support for next-generation sequencing (NGS), […]","protected":false},"featured_media":0,"parent":0,"template":"","class_list":["post-213","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"\n